Fundz

Commit Biologics raised €5.5 million in a seed funding round led by Korys to advance its BiCE platform for cancer treatments.

PRIVATEFeb 01, 2025

Amount Raised

€5.5 Million

Round Type

Seed

AarhusBiotechnologyHealth CareTherapeutics

Investors

Novo HoldingsBioqube VenturesKorys

Description

Commit Biologics announced a €5.5 million extension to its seed funding, bringing the total seed funding raised to €21.5 million. The funding will be used to advance the BiCE platform and work towards drug candidate selection, extending Commit’s runway into late 2026.

Quick answer

Commit Biologics raised €5.5 Million in a Seed round, dated February 1, 2025. Investors: Novo Holdings, Bioqube Ventures and Korys. Commit Biologics is based in Aarhus, Central Denmark Region, Denmark.

How much did Commit Biologics raise?
Commit Biologics raised €5.5 Million in a Seed round on February 1, 2025.
Who invested in Commit Biologics?
Novo Holdings, Bioqube Ventures and Korys are named as investors in this round.
What does Commit Biologics do?
Commit Biologics is a company specializing in activating the complement system to treat cancer and autoimmune diseases using their unique Bispecific Complement Engaging (BiCE™) platform.
Where is Commit Biologics based and how big is it?
Commit Biologics is based in Aarhus, Central Denmark Region, Denmark. Fundz records about 20 employees.
Who are the decision-makers at Commit Biologics?
Fundz holds 1 contact at Commit Biologics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Commit Biologics that raised within 45 days of this round, from Fundz verified event records.

  • Lipella Pharmaceuticals raised $9K (Seed) on March 17, 2025.
  • StimOxyGen raised $2M on March 11, 2025.
  • HelloBetter raised $6.4M (Funding Round) on March 5, 2025.
  • TRIMTECH Therapeutics raised $31M (Seed) on March 5, 2025.
  • Whitehawk Therapeutics, Inc. raised $100M on March 4, 2025.
  • Callio Therapeutics raised $187M (Series A) on March 3, 2025.

Who to call at Commit Biologics, and when

A new round usually means Commit Biologics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Commit Biologics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Commit Biologics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Commit Biologics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Commit Biologics

Location

Aarhus, Central Denmark Region, Denmark

About

Commit Biologics is a company specializing in activating the complement system to treat cancer and autoimmune diseases using their unique Bispecific Complement Engaging (BiCE™) platform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Commit Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Commit Biologics's next move

See what Strategic adds

Commit Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.